Glutathione S-Transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from Southern Italy

Anticancer Research

Volumn 22, Issue 6 B, 2002, Pages 3647-3652

  Sgambato, Alessandro ^a,b   Campisi, Biagina ^b   Zupa, Angela ^b   Bochicchio, Annamaria ^b   Romano, Gianpiero ^b   Tartarone, Alfredo ^b   Galasso, Rocco ^b   Traficante, Antonio ^b   Cittadini, Achille ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b REFERRAL CANCER CENTER OF BASILICATA   (Italy)

Author keywords

Cancer susceptibility; Colorectal cancer; Epidemiology; Glutathione S Transferase (GST); GSTM1; GSTT1; Southern Italy

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENZYME ACTIVITY; ETHNIC DIFFERENCE; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HOMOZYGOSITY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PRIORITY JOURNAL; RISK ASSESSMENT; SEX RATIO;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASMS; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; STOMACH NEOPLASMS;

EID: 0036875469     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Parkin D M: Global cancer statistics in the year 2000. Lancet Oncol 2: 533-43, 2001.
2. Perera FP: Molecular epidemiology: on the path to prevention? J Natl Cancer Inst 92: 602-612, 2000.
3. Raunio H, Husgafvel PK, Anttila S, Hietanen E, Hirvonen A and Pelkonen O: Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility - a review. Gene 159: 113-121, 1995.
4. Roots I, Drakoulis N and Brockmoller J: Polymorphic enzymes and cancer risk; concepts, methodology and data review in Pharmacogenetics of Drug Metabolism (Kalow, W., ed), pp. 815-841, Pergamon Press, New York, 1992.
5. Caporaso N, Landi MT and Vineis P: Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. Pharmacogenetics 1: 4-19, 1991.
6. Seidegard J, Vorachek WR, Pero RW and Pearson WR: Hereditary differences in the expression of the human glutathione transferase active on trans-stillbene oxide are due to a gene deletion. Proc Natl Acad Sci U.S.A. 85: 7293-7297, 1988.
7. Nelson HH, Wiencke JK, Christiani DC, Cheng TJ, Zuo ZF, Schwartz BS, Lee BK, Spitz MR, Wang M, Xu X and Kelsey KT: Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 16: 1243-1245, 1995.
8. Rebbeck TR: Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarker Prev 6: 733-743, 1997.
9. Sant M, Gatta G, Valente F, Barchielli A, Ramazzotti V, Serventi, L and Rosso S: The ITACARE study. Tumori 83:17-24, 1997.
10. Balzi D, Bidoli E, Franceschi S, Arniani S, Pisani P and Geddes M: Estimates of Cancer Incidence and Mortality in Italian Regions (Tumori, A.I.R., Ed.), Servizio di Epidemiologia Centro di Riferimento Oncologico, Aviano (PN), Italy, 1997.
11. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning, Second Ed. (Press, C.S.H.L., Ed.), New York, 1989.
12. Bell DA, Taylor JA, Paulson DF, Robertson, CN, Mohler JL and Lucier GW: Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene Glutathione S-Transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 85: 1159-1164, 1993.
13. Falck GC, Hirvonen A, Scarpato R, Saarikoski ST, Migliore L and Norppa H: Micronuclei in blood lymphocytes and genetic polymorphism for GSTM1, GSTT1 and NAT2 in pesticide-exposed greenhouse workers. Mutat Res 441: 225-237, 1999.
14. Peluso M, Airoldi L, Armelle M, Martone T, Coda R, Malaveille C, Giacomelli G, Terrone C, Casetta G and Vineis P: White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study. Cancer Epidemiol Biomarker Prev 7: 341-346, 1998.
15. Verdina A, Galati R, Falasca G, Ghittori S, Imbriani M, Tomei F, Marcellini L, Zijno A and Vecchio VD: Metabolic polymorphisms and urinary biomarkers' in subjects with low benzene exposure. J Toxicol Environ Health A 64: 607-618, 2001.
16. Chenevix-Trench G, Young J, Coggan M and Board P: Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis 16: 1655-1657, 1995.
17. Helzlsouer KJ, Selmin O, Huang H-Y, Strickland PT, Hoffman S, Alberg AJ, Watson M, Comstock GW and Bell D: Association between Glutathione S-transferase M1, P1 and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst 90: 512-518, 1998.
18. Zhong S, Wyllie AH, Barnes D, Wolf CR and Spurr NK: Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14: 1821-1824, 1993.
19. Hayes JD and Pulford DJ: The glutathione S-transferase supergene family: regulation of GST and contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600, 1995.
20. Garcia-Closas M, Kelsey KT, Hankinson SE, Spiegelman D, Springer K, Willett WC, Speizer FE and Hunter DJ: Glutathione S-transferase Mu and Theta polymorphisms and breast cancer susceptibility. J Natl Cancer Inst 91: 1960-1964, 1999.